VANGUARD GROUP INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 167 filers reported holding CARDLYTICS INC in Q4 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$33,193,132
+195.0%
2,011,705
+13.0%
0.00%
Q2 2023$11,252,141
+86.4%
1,780,402
+0.1%
0.00%
Q1 2023$6,038,014
-56.3%
1,778,502
-25.7%
0.00%
Q4 2022$13,830,135
-51.2%
2,392,757
-20.6%
0.00%
-100.0%
Q3 2022$28,317,000
-57.1%
3,012,412
+1.8%
0.00%
-50.0%
Q2 2022$66,012,000
-59.0%
2,958,847
+1.0%
0.00%
-50.0%
Q1 2022$161,005,000
-16.1%
2,928,435
+0.8%
0.00%0.0%
Q4 2021$191,994,000
-20.7%
2,905,042
+0.7%
0.00%
-33.3%
Q3 2021$242,151,000
-33.3%
2,884,810
+0.8%
0.01%
-33.3%
Q2 2021$363,217,000
+21.1%
2,861,557
+4.6%
0.01%
+12.5%
Q1 2021$299,976,000
+14.4%
2,734,513
+48.9%
0.01%0.0%
Q4 2020$262,231,000
+179.0%
1,836,743
+37.9%
0.01%
+166.7%
Q3 2020$93,995,000
+4.7%
1,331,938
+3.8%
0.00%0.0%
Q2 2020$89,815,000
+139.9%
1,283,434
+19.8%
0.00%
+50.0%
Q1 2020$37,446,000
-42.9%
1,071,083
+2.7%
0.00%0.0%
Q4 2019$65,550,000
+103.0%
1,042,799
+8.2%
0.00%
+100.0%
Q3 2019$32,296,000
+64.6%
963,467
+27.6%
0.00%0.0%
Q2 2019$19,618,000
+129.5%
755,132
+46.1%
0.00%
Q1 2019$8,550,000
+58.7%
516,921
+3.9%
0.00%
Q4 2018$5,388,000
-46.9%
497,578
+22.8%
0.00%
Q3 2018$10,146,000
+74.7%
405,202
+51.8%
0.00%
Q2 2018$5,809,000
+116.2%
266,978
+45.4%
0.00%
Q1 2018$2,687,000183,6350.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders